Apollomics Investor Relations Material
Latest events
Q2 2024
14 Aug, 2024
Q4 2023
28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Apollomics Inc
Access all reports
Apollomics Inc. is a biopharmaceutical company focused on the discovery and development of oncology treatments. The company specializes in targeted therapies and immuno-oncology drugs designed to address various types of cancer. Apollomics conducts clinical research to advance its pipeline of investigational therapies, through innovative approaches such as small molecules and monoclonal antibodies. The company is headquartered in Foster City, California, and its shares are listed on the NASDAQ.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
APLM
Country
🇺🇸 United States